The ILLUMINATE-101 Study is a phase 2 clinical research study evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.
In order to qualify, one must:
- Be between 18 and 75 years old
- Have biopsy-confirmed celiac disease that is generally well-controlled
- Have been on a gluten-free diet for at least the past 6 months
Some study visits can be completed at home, and all study-related care will be provided at no cost. Reimbursement for travel-related expenses is available.
To learn more, please visit: illuminatecd-cdf.com.
Enroll in a Celiac Disease Research Study Today